Werner Poewe, MD
(University Hospital of Neurology)
|
Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities. |
Wolfgang H. Oertel, MD, FAAN
(Philipps-University Marburg)
|
Dr. Oertel has received personal compensation for serving as an employee of ParkinsonFonds Deutschland. Dr. Oertel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IntraBio, UK. Dr. Oertel has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for MODAG Germany. The institution of Dr. Oertel has received research support from Stichting ParkinsonFonds, The Netherlands,. The institution of Dr. Oertel has received research support from Michael J Fox Foundation. |